Related Experiment Video
Updated: Apr 11, 2026

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation
Published on: February 28, 2012
[The subcutaneous cardioverter-defibrillator: When less is more]
1Deutsches Zentrum für Herz- Kreislaufforschung (DZHK) e.G., Universitätsmedizin Mannheim, I. Medizinische Klinik, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Deutschland, juergen.kuschyk@umm.de.
The subcutaneous implantable cardioverter-defibrillator (S-ICD) offers an alternative to transvenous systems, avoiding complications. Studies show its efficacy and safety are comparable or superior, making it suitable for many patients needing defibrillator therapy.
Area of Science:
- Cardiology
- Medical Devices
- Electrophysiology
Background:
- Defibrillator therapy, including implantable cardioverter-defibrillators (ICDs), has significantly advanced sudden cardiac death prevention.
- Transvenous ICD (TV-ICD) systems are associated with specific periprocedural and long-term complications.
- The subcutaneous ICD (S-ICD) system offers a transvenous-free approach, potentially mitigating these risks and eliminating the need for fluoroscopy during implantation.
Purpose of the Study:
- To evaluate the efficacy and safety of the S-ICD system.
- To compare S-ICD performance against traditional TV-ICD systems.
- To identify patient populations and clinical scenarios where S-ICD is particularly suitable.
Main Methods:
- Multicenter studies and registries were utilized to assess S-ICD performance.
- Cardiac rhythm detection is managed through three potential vectors, with automatic selection of the optimal vector.
- The S-ICD system is capable of delivering high-energy shocks and provides postshock pacing.
Main Results:
- The S-ICD system demonstrated efficacy and safety profiles equal to or better than TV-ICD systems in multicenter studies and registries.
- Initial challenges such as inappropriate shocks and infections have been addressed through standardized implantation techniques, operator experience, and algorithm modifications.
- The S-ICD is considered a viable option for patients with challenging anatomy or a history of infection.
Conclusions:
- The S-ICD is a suitable option for most patients indicated for defibrillator therapy, excluding those requiring pacing, cardiac resynchronization therapy (CRT), or those with specific ventricular tachycardia rates or negative screening results.
- The S-ICD system has received regulatory approval (CE in 2009, FDA in 2012) and is recognized for reimbursement in some healthcare systems.
- Ongoing advancements in implantation techniques and algorithms continue to enhance the performance and safety of the S-ICD system.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Cardiopulmonary Resuscitation III: AED Use
Heart Failure VI: Adjunct Therapies
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiac Catheterization IV: Nursing Management
Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices

